0001806952 2026-07-10 2026-07-10 0001806952 1 2026-07-10 2026-07-10 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001806952 Lyell Immunopharma, Inc. N/A N/A S-3 Lyell Immunopharma, Inc. false Equity Common Stock, par value $0.0001 per share true 1100000 14.63 16093000.00 0.0001381 2222.45 16093000.00 2222.45 0.00 0.00 2222.45 Consists of an aggregate of 1,100,000 shares of the registrant's common stock, all of which were acquired by the selling stockholder on July 10, 2026 upon the achievement of certain milestones as partial consideration for an exclusive license agreement. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of registrant's common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of stock splits, stock dividends or similar transactions. Pursuant to Rule 457(c), calculated on the basis of the average of the high and low prices per share of common stock reported on The Nasdaq Stock Market on July 10, 2026.